Abstract:A major pathway in hypertension pathogenesis involves direct activation of ANG II type 1 (AT1) receptors in the kidney, stimulating Na+ reabsorption. AT1 receptors in tubular epithelia control expression and stimulation of Na+ transporters and channels. Recently, we found reduced blood pressure and enhanced natriuresis in mice with cell-specific deletion of AT1 receptors in smooth muscle (SMKO mice). Although impaired vasoconstriction and preserved renal blood flow might contribute to exaggerated urinary Na+ excretion in SMKO mice, we considered whether alterations in Na+ transporter expression might also play a role; therefore, we carried out proteomic analysis of key Na+ transporters and associated proteins. Here, we show that levels of Na+-K+-2Cl- cotransporter isoform 2 (NKCC2) and Na+/H+ exchanger isoform 3 (NHE3) are reduced at baseline in SMKO mice, accompanied by attenuated natriuretic and diuretic responses to furosemide. During ANG II hypertension, we found widespread remodeling of transporter expression in wild-type mice with significant increases in the levels of total NaCl cotransporter, phosphorylated NaCl cotransporter (Ser71), and phosphorylated NKCC2, along with the cleaved, activated forms of the α- and γ-epithelial Na+ channel. However, the increases in α- and γ-epithelial Na+ channel with ANG II were substantially attenuated in SMKO mice. This was accompanied by a reduced natriuretic response to amiloride. Thus, enhanced urinary Na+ excretion observed after cell-specific deletion of AT1 receptors from smooth muscle cells is associated with altered Na+ transporter abundance across epithelia in multiple nephron segments. These findings suggest a system of vascular-epithelial in the kidney, modulating the expression of Na+ transporters and contributing to the regulation of pressure natriuresis.NEW & NOTEWORTHY The use of drugs to block the renin-angiotensin system to reduce blood pressure is common. However, the precise mechanism for how these medications control blood pressure is incompletely understood. Here, we show that mice lacking angiotensin receptors specifically in smooth muscle cells lead to alternation in tubular transporter amount and function. Thus, demonstrating the importance of vascular-tubular cross talk in the control of blood pressure.

Stimulation of the Renal Kallikrein-Kinin System by Vasoactive Substances and Its Relationship to the Excretion of Salt and Water1

Kallikrein–kinin in stroke, cardiovascular and renal disease

Chemical Stimulation of Renal Tissue Induces Sympathetic Activation and a Pressor Response Via the Paraventricular Nucleus in Rats

Role of oxidative stress in the natriuresis induced by central administration of angiotensin II

Sensitivities of rat kidney thick ascending limbs and collecting ducts to vasopressin in vivo

Interaction of Angiotensin-(1-7) with kinins in the kidney circulation: Role of B1 receptors

Renal Prostaglandins in the Control of Renin1

Renal Medulla in Hypertension

Diuretic response to acute hypertension is blunted during angiotensin II clamp.

Pressure natriuresis and the renal control of arterial blood pressure

Effects of Acute Haemodialysis-Induced Changes in Sodium Balance upon Experimentally Hypertensive Rats

Vascular control of kidney epithelial transporters

Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system.

Prostaglandins and Renal Function

Kidney collecting duct cells make vasopressin in response to NaCl-induced hypertonicity

Atrial Natriuretic Peptide Stimulates Dopamine Tubular Transport by Organic Cation Transporters: A Novel Mechanism to Enhance Renal Sodium Excretion

Intra-Renal Factors in Renin Release

What Makes the Renin-Angiotensin System a Pathogenic Factor?

Effects of intrarenal pelvic infusion of tumour necrosis factor-α and interleukin 1-β on reno-renal reflexes in anaesthetised rats

Calcitonin gene products and the kidney

Altered Expression of Renal Bumetanide-Sensitive Sodium-Potassium-2 Chloride Cotransporter and Cl- Channel -K2 Gene in Angiotensin II-infused Hypertensive Rats.